2.480EUR-1.59%Mkt Cap: 112.43M EURP/E: —Last update: 2026-05-14
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for …
Industry Peers
Medical Instruments & Supplies89.99BDKKP/E 42.8
79.57BEURP/E 34.7
17.63BSEKP/E 31.2
15.17BEURP/E 56.5
14.15BEURP/E 87.2
11.38BEURP/E 70.1
3.57BEURP/E 19.6
2.18BEURP/E 15.5
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-1.76
PEG—
P/B3.10
P/S7.33
EV/EBITDA-1.49
EV/Revenue7.92
EPS (TTM)-2.36
EPS (Forward)-1.47
Cash Flow & Leverage
FCF Yield-38.73%
FCF Margin-284.10%
Operating CF-68.98M EUR
CapEx (TTM)3.77M EUR
Net Debt/EBITDA-0.12
Net Debt10.15M EUR
Technical
SMA 502.709 (-8.4%)
SMA 2004.040 (-38.6%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)95.42K
Avg Vol (10d)107.10K
Technical Indicators
RSI (14)40.4
MACD-0.0489
MACD Signal-0.0531
MACD Hist.+0.0042
BB Upper2.890 EUR
BB Middle2.658 EUR
BB Lower2.426 EUR
BB Width17.46%
ATR (14)0.1804 EUR
Vol Ratio (20d)1.76x
52W Range
2.3502% of range8.870
52W High8.870 EUR
52W Low2.350 EUR
Profitability
Gross Margin63.13%
EBITDA Margin0.00%
Profit Margin-899.05%
Oper. Margin-321.72%
ROE-183.36%
ROA-76.04%
Revenue Growth498.90%
Earnings Growth—
Balance Sheet
Debt/Equity0.82
Current Ratio0.99
Quick Ratio0.86
Book Value/Sh0.8300 EUR
Cash/Share0.6000 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.43.66M
Float24.24M
Insiders37.04%
Institutions23.52%
Analyst Consensus
Rating—
Target (Mean)9.000 EUR
Target Range3.500 EUR – 13.00 EUR
# Analysts3
Company
Market Cap112.43M EUR
Enterprise Value121.41M EUR
Revenue (TTM)15.33M EUR
Gross Profit6.33M EUR
Net Income (TTM)-90.08M EUR
Revenue/Share0.3880 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees153
Last Price2.480 EUR
CountryBE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—